Related Experiment Video
Updated: Aug 13, 2026
08:18
A Model of Chronic Nutrient Infusion in the Rat
Published on: August 14, 2013
Summary
High blood sugar significantly enhances sugar transport in the small intestine by increasing glucose, galactose, and 3-O-Methylglucose (3-O-MG) absorption. This effect is mediated by new carrier sites, likely in the basolateral membrane, induced by sustained hyperglycemia.
Area of Science:
- Physiology
- Endocrinology
- Gastroenterology
Background:
- Diabetes mellitus is characterized by hyperglycemia, potentially affecting nutrient absorption.
- Intestinal sugar transport mechanisms are crucial for glucose homeostasis.
- Previous studies suggested altered intestinal function in diabetic states.
Purpose of the Study:
- To investigate the impact of experimental diabetes and hyperglycemia on sugar transport in the isolated small intestine.
- To elucidate the mechanisms underlying enhanced intestinal sugar absorption in diabetic rats.
- To determine the role of hyperglycemia and other factors in modulating sugar transport.
Main Methods:
- Utilized streptozotocin-induced diabetic rats and in vivo/in vitro intestinal perfusion models.
- Measured the transport rates of glucose, galactose, 3-O-Methylglucose (3-O-MG), and fructose across the intestinal epithelium.
- Investigated the effects of hyperglycemia, hypergalactosemia, hyperfructosemia, and pharmacological inhibitors (phloretin, phlorizin, cycloheximide).
Main Results:
- Isolated small intestine showed increased mucosal-to-serosal flux for glucose, galactose, and 3-O-MG in diabetic rats.
- Enhanced transport was independent of streptozotocin toxicity or insulin deficiency.
- Sustained hyperglycemia (4 hours) mimicked the diabetic effect on sugar transport, suggesting a regulatory mechanism.
- Hyperglycemia and hypergalactosemia enhanced transport of glucose, galactose, and 3-O-MG, while hyperfructosemia specifically increased fructose transport.
- The effect of hyperglycemia was inhibited by phloretin and cycloheximide, but not phlorizin.
Conclusions:
- Sustained hyperglycemia induces an adaptive increase in intestinal sugar transport capacity.
- The enhanced transport is likely mediated by the synthesis of new sugar carrier proteins.
- These new carriers are proposed to be located in the basolateral membrane of intestinal epithelial cells.
- This finding has implications for understanding nutrient absorption and metabolic regulation in diabetes.
More Related Videos
08:03Glucose Uptake Measurement and Response to Insulin Stimulation in In Vitro Cultured Human Primary Myotubes
Published on: June 25, 2017
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)
Published on: January 7, 2018
Related Concept Videos
01:27Glucose Transporters
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
01:26Glucose Absorption Into the Small Intestine
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and 'exit' via the...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.